Publisher
Springer Berlin Heidelberg
Reference5 articles.
1. Roggenbuck D, Hausdorf G, Martinez-Gamboa L, Feist E, Büttner T, Reinhold D, Jungblut PR, Porstmann T, Laass MW, Büning C, Henker J, Conrad K (2009a) Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn’s disease. Gut 58:1620–1628
2. Roggenbuck D, Hausdorf G, Martinez-Gamboa L, Reinhold D, Büttner T, Büning C, Feist E, Conrad K (2009b) The zymogen granule membrane glycoprotein GP2 is a major autoantigen of pancreatic antibodies – relevance in diagnostics and pathogenesis of Crohn’s disease. In: Conrad K et al (Hrsg) From pathogenesis to therapy of autoimmune diseases. Lengerich: Pabst Science Publishers, S 449–462
3. Stöcker W, Otte M, Ulrich S, Normann D, Stöcker K, Jantschek G (1984) Autoantikörper gegen exokrines Pankreas und gegen intestinale Becherzellen in der Diagnostik des Morbus Crohn und der Colitis ulcerosa. Dtsch Med Wochenschr 109:1963–1969
4. Stöcker W, Otte M, Ulrich S, Normann D, Finkbeiner H, Stöcker K, Jantschek G, Scriba PC (1987) Autoimmunity to pancreatic juice in Crohn’s disease. Results of an autoantibody screening in patients with chronic inflammatory bowel disease. Scand J Gastroenterol Suppl 139:41–52
5. Stöcker W, Teegen B, Probst C, Aulinger-Stöcker K, Ludwig D, Glocker MO, Komorowski L (2009) CUZD1 and GP2 are the exocrine pancreas autoantigens in Crohn’s disease. In: Conrad K et al (Hrsg) From pathogenesis to therapy of autoimmune diseases. Pabst Science Publishers, S 463–473